Centinel Spine reports $132m funding round

This article was originally published here
Share

Centinel SpineFresh from its acquisition of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes’ Prodisc assets, Centinel Spine last week reported raising more than $132 million.

In the waning days of 2017, Centinel it closed its acquisition of DePuy’s Prodisc-C, Prodisc-L, Prodisc-C Vivo, Prodisc-C Nova, Prodisc-O and Discover cervical and lumbar artificial disc systems. Although the purchase price remained undisclosed, Centinel said at the time that the deal was funded with debt and equity, with Piper Jaffray as its placement agent.

In a Jan. 12 regulatory filing, Centinel said it brought in $132.3 million in a Dec. 19 offering of equity, debt, options, warrants and other securities from nine unnamed investors. Piper Jaffray earned a $4.2 million sales commission on the offering, according to the filing.

Last June, Centinel Spine said it won Australian Therapeutic Goods Administration clearance for its Stalif L no-profile lateral lumbar integrated interbody system.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply